The authors predicted 231 hairpins in the 305-kb WSSV genome (Vmir + RNAfold), microarray-screened 231 candidates, and confirmed 106 positive signals, of which 40 miRNAs passed microarray plus LNA-northern-blot validation; 32 were detected at 2 h post-infection (early phase, before the 6 h onset of genome replication) (). Mechanistically, siRNA silencing of shrimp Drosha or Dicer1 abolished detection of WSSV-miR197, and EMSA showed binding to recombinant GST-Ago1 but not GST β a reasonable demonstration that the canonical host microprocessor processes viral miRNAs. AMO (LNA/MOE/phosphorothioate) silencing of miR-211 or miR-212 significantly lowered WSSV copies from 36 h onward (n=3 replicate assays, 10 shrimp/treatment; p<0.05, p<0.01), supporting a proviral role for these two miRNAs. The claim that WSSV carries ~360Γ the human miRNA density is an arithmetic framing device, not a functional finding.
Critical caveats: (1) The target network (Table 1) is entirely computational β TargetScan seed matches plus miRanda (ΞG < β20 kcal/mol, score > 50) β with no reporter or RISC-CLIP validation for any listed interaction; miR-212's 35 predicted targets include homopolymeric miRNAs (miR-158, miR-164, miR-212 are U/C-rich repeats), which are exactly the sequences most prone to false-positive seed matches. (2) Functional validation covered only miR-211 and miR-212, described as "randomly selected," yet miR-211 was not detected at 2 h β an inconsistency with the early-miRNA rationale. (3) AMOs can have off-target effects; the mutated-AMO control mitigates but does not exclude this, and no dose-response was reported. (4) The premise that viral miRNAs "were required for successful WSSV infection" overstates reduced-but-not-abolished viral copy data; no survival endpoint was reported for AMO treatments. (5) Only one shrimp species (M. japonicus) and one WSSV isolate (AF332093) were tested, limiting generalizability. Notably, later work from the same group went further mechanistically: WSSV-miR-22 was shown to directly target the host STAT 3'UTR, inhibiting the JAK/STAT-TEP1/TEP2 antiviral axis (), and host miR-7 targets the viral wsv477 3'UTR with ~1000-fold effects on genome copies () β both exemplify the validation standard this catalog paper itself did not meet. Confidence in the catalog (40 miRNAs, expression timing): moderate; confidence in the target map: low pending wet-lab validation.
What would change these conclusions: small-RNA-seq with independent replicates failing to recover most of the 40 loci, or luciferase reporters showing seed-site-independent effects, would substantially weaken the catalog; rescue of AMO effects with miRNA mimics resistant to the AMO would strengthen causality.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.